Delivery Order SPE2DB22D3010-SPE2DB26FP0UU
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, valued at $1,083.05, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of June 2, 2025. The place of performance is located at the vendor's corporate office in...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,340.28 by the Defense Logistics Agency on August 4, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract represents a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by August 5, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,119.28 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,772.20 on September 19, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, was issued without a set-aside designation and represents a competitively awarded procurement through the Defense Logistics Agency's Medical Supply Chain. The...
- The Defense Logistics Agency awarded a $21,188.72 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, valued at $16,549.76, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $13,116.38 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $10,594.36 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under the company's larger...
- The Defense Logistics Agency awarded a $73,842.39 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of October 15, 2025. This non-set-aside delivery order was competitively awarded on October 14, 2025, to support federal medical procurement needs within the military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB26FP0UUDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $21,054.69 on October 31, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, which is expected to be completed by November 3, 2025, was competitively awarded without a set-aside designation by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for managing the military's supply chain. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. The Repatha supply fulfills critical medical needs for the Defense Health Agency and other federal healthcare systems, as this cardiovascular medication is essential for cholesterol management in military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.1k | 10/31/25 |